Cellectis
CLLS
43 hedge funds and large institutions have $181M invested in Cellectis in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
30% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 10
8% more funds holding
Funds holding: 40 → 43 (+3)
24% less capital invested
Capital invested by funds: $238M → $181M (-$56.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$3.96M |
| 2 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
+$2.13M |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$1.36M |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$1.29M |
| 5 |
PA
Perceptive Advisors
New York
|
+$1.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.43M |
| 2 |
GTC
Ghost Tree Capital
New York
|
-$1.67M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.15M |
| 4 |
FMA
FNY Managed Accounts
New York
|
-$267K |
| 5 |
Morgan Stanley
New York
|
-$231K |
CLLS Hedge Fund Activity: Q3 2015 in Review
43 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q3 2015, worth a combined $181M — down 24% from $238M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CLLS positions and 4 closed out — a net gain of 3 holders — while 13 added to existing stakes and 10 trimmed.
The largest buyer was Tekla Capital Management, adding an estimated $3.96M. The largest seller was Millennium Management, cutting an estimated $2.43M.
- 43 institutional investors held Cellectis (CLLS) as of Q3 2015, up from 40 in Q2 2015.
- Funds reported $181M of Cellectis stock for Q3 2015, down 24% quarter-over-quarter.
- 7 funds opened new Cellectis positions in Q3 2015 and 4 closed out, a net change of +3 holders.
- The largest Cellectis buyer in Q3 2015 was Tekla Capital Management, an estimated $3.96M added.
- The largest Cellectis seller in Q3 2015 was Millennium Management, an estimated $2.43M sold.
Based on aggregated 13F filings for Q3 2015.